John Paul Johnson, Chief Financial Officer at Evolent Health, Inc. (EVH), sold 44,693 shares at $30.00 ($1.3M) on 2024-08-22, disclosed to the SEC on 2024-08-26.
Scheduled sale ($1.3M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.